Trials / Completed
CompletedNCT05927714
Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane
Palatal Donor Site Wound Healing Following Periodontal Plastic Surgery Using Amnion-Chorion Membrane: Site- and Patient-Centered Outcomes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- The University of Texas Health Science Center at San Antonio · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this clinical trial is to assess if donor site healing in the palatal area and patient pain perception are similar or different when using amnio-chorion membrane (ACM) on the donor site after surgery compared to a commonly used commercial hemostatic agent (ActCel Cellulose Gauze).
Detailed description
Resorbable oxidized cellulose materials are commonly used as hemostatic agents in medicine and dentistry. Surgicel and ActCel are used daily in surgical practice. When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding. ActCel is water-soluble and dissolves over a short time period. It can be removed easily when water, saline or hydrogen peroxide is applied.The study team will examine the effects of ACM as a wound dressing for the donor area and compare the rate of epithelialization with and without its use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Amnion-chorion Membrane | Amnio-chorion membranes specifically for palatal wound healing following free soft tissue autografts (FTSA) procedures. |
| OTHER | ActCel Cellulose Gauze | When these products come in contact with blood, they convert to a gel that expands to cause direct pressure on blood vessels and control bleeding. ActCel is water-soluble and dissolves over a short time period. It can be removed easily when water, saline or hydrogen peroxide is applied. |
Timeline
- Start date
- 2023-09-11
- Primary completion
- 2025-04-03
- Completion
- 2025-04-03
- First posted
- 2023-07-03
- Last updated
- 2025-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05927714. Inclusion in this directory is not an endorsement.